Vir Biotechnology
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,380 | $3,075 | $56,376 | $16,787 |
Gross Profit | 2,330 | -1,237 | 51,800 | 11,510 |
EBITDA | -210,644 | -128,095 | -75,564 | -134,537 |
EBIT | -213,540 | -132,355 | -80,081 | -139,016 |
Net Income | -213,717 | -138,378 | -65,275 | -115,973 |
Net Change In Cash | 2,380 | 3,075 | 56,376 | 16,787 |
Free Cash Flow | -173,836 | -78,513 | -111,262 | -109,462 |
Cash | 257,948 | 310,810 | 174,046 | 254,844 |
Basic Shares | 136,653 | 136,233 | 135,280 | 134,608 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $86,180 | $1,580,472 | $1,087,068 | $76,368 |
Gross Profit | 83,415 | 1,434,153 | 1,021,203 | 76,368 |
EBITDA | -684,305 | 833,068 | 420,751 | 514,328 |
EBIT | -703,756 | 817,576 | 408,768 | -298,719 |
Net Income | -615,061 | 515,837 | 528,584 | -298,665 |
Net Change In Cash | 86,180 | 1,580,472 | 1,087,068 | 76,368 |
Cost of Revenue | -88,072 | 328,671 | ||
Free Cash Flow | -800,358 | 1,595,225 | -69,406 | -197,490 |
Cash | 254,844 | 848,631 | 347,815 | 436,575 |
Basic Shares | 134,130 | 134,810 | 133,437 | 119,159 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.56 |
2024-06-30 | -$1.02 |
2024-03-31 | -$0.48 |
2023-12-31 | -$0.86 |
